Showing results (121-130 of 432) with videos related to

Sort By:
Pageof 44
Clinical Pediatrics|December 24, 2023
PICU Admission of Children for Status Epilepticus: Is There a Different Approach Between Referral and Second-Level Hospitals in an Italian Region?Claudia Maria Bonardi, Margherita Nosadini, Giulia Lorenzoni, et al.
Cancer|March 20, 2002
A randomized, multicenter prospective trial assessing long-acting release octreotide pamoate plus tamoxifen as a first line therapy for advanced breast carcinomaEmilio Bajetta, Giuseppe Procopio, Leonardo Ferrari, et al.
Tumori|August 10, 2019
Phase I studies: a test bench for Italian clinical researchCeleste Cagnazzo, Oriana Nanni, Francesca Arizio, et al.
Tumori|May 11, 2006
Neuroendocrine tumors of the larynx: a clinical report and literature reviewGiuseppe Procopio, Riccardo Ricotta, Alberto Fusi, et al.
Personalized Medicine|December 7, 2021
Biomarker-driven immunotherapy for precision medicine in prostate cancerArianna Ottini, Pierangela Sepe, Teresa Beninato, et al.
Frontiers in Oncology|September 9, 2020
Predictive Biomarkers of Response to Immunotherapy in Metastatic Renal Cell CancerAlessandra Raimondi, Pierangela Sepe, Emma Zattarin, et al.
Pediatric Nephrology (Berlin, Germany)|June 19, 2026
Hemoadsorption in acute pediatric carbamazepine intoxication: a case report and systematic review of extracorporeal therapiesDavide Visentin, Germana Longo, Anna Tessari, et al.
European Urology Oncology|August 22, 2025
A Deep Prostate-specific Antigen Response to Darolutamide plus Androgen Deprivation Therapy Is Associated with Better Clinical Outcomes in the Phase 3 ARANOTE Trial in Patients with Metastatic Hormone-sensitive Prostate CancerFred Saad, Alberto Briganti, Kunhi Parambath Haresh, et al.
Cancers|December 19, 2020
Microwave Ablation Versus Radiofrequency Ablation for Treatment of Hepatocellular Carcinoma: A Meta-Analysis of Randomized Controlled TrialsAntonio Facciorusso, Mohamed A Abd El Aziz, Nicola Tartaglia, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|August 29, 2015
Bone metastases affect prognosis but not effectiveness of third-line targeted therapies in patients with metastatic renal cell carcinomaRoberto Iacovelli, Daniele Santini, Mimma Rizzo, et al.
Pageof 44